Tillbaka
Pelgraz - a pegylated G-CSF Biosimilar, is latest addition to Accord Healthcare's established portfolio of over 30 oncology treatments across Europe
https://www.prnewswire.com/news-releases/accord-healthcare-s-intas-pelgr...